# Amneal Pharmaceuticals, Inc. (AMRX) FY2026 YTD Q2 Statement of Cash Flows

- Company: Amneal Pharmaceuticals, Inc. (AMRX)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001723128-26-000031
- Page: https://plicit.ai/financials/amrx/fy2026-ytd-q2-cash-flow
- Chart image: https://plicit.ai/charts/amrx-fy2026-ytd-q2-cash-flow-sankey.png

## Chart details

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

- **Beginning cash on Dec 31, 2025**: 312,939,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- **Operating activities**: negative 47,987,000 US dollars. Net cash used.
- **Net income**: 147,614,000 US dollars
- **Depreciation and amortization**: 90,991,000 US dollars
- **Unrealized foreign currency loss (gain)**: 10,495,000 US dollars
- **Amortization of debt issuance costs and discount**: 7,954,000 US dollars
- **Stock-based compensation**: 19,208,000 US dollars
- **Inventory provision**: 44,957,000 US dollars
- **Other operating charges and credits, net**: 3,086,000 US dollars
- **Trade accounts receivable, net**: negative 125,765,000 US dollars
- **Inventories**: negative 124,150,000 US dollars
- **Prepaid expenses, other current assets and other assets**: negative 24,150,000 US dollars
- **Related party receivables**: 25,000 US dollars
- **Accounts payable, accrued expenses and other liabilities**: negative 57,918,000 US dollars
- **Related party payables**: negative 49,632,000 US dollars
- **Reclassification of cash flow hedge**: 5,788,000 US dollars
- **Loss on refinancing**: 3,510,000 US dollars
- **Investing activities**: negative 144,452,000 US dollars. Net cash used.
- **Purchases of property, plant and equipment**: negative 38,872,000 US dollars
- **Acquisition of intangible assets**: negative 85,000,000 US dollars
- **Deposits for future acquisition of property, plant and equipment**: negative 20,580,000 US dollars
- **Proceeds from sale of property, plant and equipment**: 0 US dollars
- **Financing activities**: 20,306,000 US dollars. Net cash provided.
- **Payments of principal on debt, revolving credit facilities, financing leases and other**: negative 147,027,000 US dollars
- **Proceeds from issuance of debt**: 134,673,000 US dollars
- **Payments of deferred financing and refinancing costs**: negative 1,982,000 US dollars
- **Borrowings on revolving credit facilities**: 100,000,000 US dollars
- **Proceeds from exercise of stock options**: 80,000 US dollars
- **Employee payroll tax withholding on restricted stock unit and performance stock unit vesting**: negative 44,481,000 US dollars
- **Tax and other distributions to non-controlling interests**: negative 21,067,000 US dollars
- **Proceeds from alliance party**: 510,000 US dollars
- **Acquisition of non-controlling interest**: negative 400,000 US dollars
- **Operating adjustment reconciliation**: 381,615,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- **financing gross reconciliation**: 235,263,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **investing gross reconciliation**: 144,452,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **Exchange-rate effect**: negative 1,187,000 US dollars
- **Ending cash on Jun 30, 2026**: 139,619,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- **Cash sources and uses**: 333,245,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- **Net cash change**: negative 173,320,000 US dollars. Ending cash minus beginning cash.
- **Cash flow / Net income**: −0.33×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
- **Operating cash flow**: negative 47,987,000 US dollars. Operating cash flow used in the free cash flow calculation.
- **Cash purchases of property, plant and equipment**: 38,872,000 US dollars. These cash purchases are already included in investing activities above.
- **Free cash flow**: negative 86,859,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

### Chart connections

- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net income or operating cash is negative. The full signed reconciliation is retained: losses remain deductions, and any negative operating-cash total enters the junction from the cash pool. No positive direct-income connection is implied.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: negative 47,987,000 US dollars minus 38,872,000 US dollars equals negative 86,859,000 US dollars.